Dimensional Fund Advisors’s Xeris Biopharma Holdings XERS Stock Holding History
Bought
Maintained
Sold
Other funds holding XERS
Dimensional Fund Advisors's XERS Position: Q3 2026 in Review
Dimensional Fund Advisors increased its Xeris Biopharma Holdings (XERS) stake by 58% in Q3 2026, buying an estimated $5.25M and bringing the position to 1,695,568 shares worth $16.2M. The position accounts for ﹤0.01% of the portfolio, ranked #2110.
Dimensional Fund Advisors first reported a position in XERS in Q2 2021 and has held it in 9 quarters since. 247 funds tracked by Wall St. Rank hold XERS as of Q3 2026.
- Dimensional Fund Advisors held 1,695,568 shares of Xeris Biopharma Holdings worth $16.2M as of Q3 2026.
- Dimensional Fund Advisors bought 621,929 Xeris Biopharma Holdings shares in Q3 2026, an estimated $5.25M.
- Xeris Biopharma Holdings made up ﹤0.01% of Dimensional Fund Advisors's portfolio in Q3 2026, its #2110 holding.
- Dimensional Fund Advisors first reported a position in Xeris Biopharma Holdings in Q2 2021 and has held it in 9 quarters since.
- 247 funds tracked by Wall St. Rank held Xeris Biopharma Holdings as of Q3 2026.
Based on Dimensional Fund Advisors's 13F filing for Q3 2026, filed 4 Nov 2026.